Menu

Meet with PPD at DIA


Your DIA experience just got sweeter! Visit booth #1319 to enjoy our candy buffet and learn more about the sweeter side of clinical research when you partner with PPD.

PPD, including Evidera, our peri- and post-approval business unit, are dedicated to helping you achieve success along the drug development and market access path. Join us at DIA to find out why we are the right partners to help you achieve sweet success.

To set up a meeting or a complimentary consulting session at DIA, please complete the form.

Please fill out the following form

Pharmaceutical Product Development, LLC and its affiliates (together “PPD”) will use the information you provide on this page for the purpose of contacting you on this subject. Important information on how PPD handles personal data and what rights you may have under data privacy laws are included within PPD’s Global Privacy Policy.


PPD at the Podium: DIA Presentations

Innovation Theater: Reimagining Study Planning and Feasibility to Create More Efficient Clinical Trials
Monday, June 25, 12:45 - 1:15 p.m., Theater 2 Exhibit Hall
Tammy D’Lugin, Executive Director, Accelerated Enrollment Solutions, PPD
Peter Wijngaard, Executive Vice President and Chief Development Officer, The Medicines Company

Changing Landscape of Managing CMC Post-Approval Changes: Challenges Now and How Global Regulations Impacts Us Going Forward
Wednesday, June 27, 8 - 9:15 a.m., Room 208
Pascha Clark-Higgs, RAC, Associate Director, Regulatory Development Solutions, CMC, PPD

Gene Therapy Clinical Trials: Current Challenges
Wednesday, June 27, 2 - 3:15 p.m., Room 156ABC
Kirsten Messmer, Principal Regulatory Affairs Specialist, PPD

Real-Life Strategies for Collaborative Stakeholder Management
Wednesday, June 27, 2 - 3:15 p.m., Room 252AB
Marina Acosta Enslen, Clinical Team Manager, PPD

Risk-Based Monitoring for Master Protocol Study: A Dilemma and Possible Ways to Go
Tuesday, June 26, 2 - 3:15 p.m., Room 258C
Rachael Cui Song, MBA, Senior Project Manager, Hematology/Oncology, PPD

The Risk Assessment is Done: Now What? A Guide to Setting Up a Centralized Monitoring Plan
Tuesday, June 26, 2 – 3:15 p.m., Room 205C
Olgica Klindworth, Director, Data Analytics, PPD

Does Sourcing Strategy Matter? Executives Debate the Influence of an Outsourcing Model on Clinical Trial Execution
Wednesday, June 27, 4 - 5:15 p.m., Room 258C
David Johnston, Executive Vice President, Clinical Development, PPD

Contact Legal Notices Modern Slavery Transparency Statement Privacy Policy

© 2018 Pharmaceutical Product Development, LLC. All rights reserved.